The Janssen Pharmaceutical Companies of Johnson & Johnson

New identity. Same purpose: Janssen is now Johnson & Johnson Innovative Medicine. Follow our new page to discover how we’re leading where medicine is going. #JNJ

Today, on World Pharmacist Day, we recognize and thank pharmacists across the globe for the essential work they do each day to help keep us all healthy. Pharmacists act as caregivers, advisors, and researchers on local and global levels providing better care and treatment options, improving patient outcomes. Join us in celebrating the incredible impact pharmacists have on our communities by sharing your stories with #YouStandByUsAll. #WorldPharmacistDay #WPD2023

Over the past year, Save Legs. Change Lives.™ has been visiting communities across the U.S. to help increase peripheral artery disease (PAD) awareness, education, and screening - the heart of real, tangible change needed to help lower the risk of PAD-related amputations. Help us continue advancing equitable healthcare for people affected by #PAD and keep the conversation going during #PADAwarenessMonth. Find patient resources here: https://bit.ly/3ZKS35v

We are advancing the discovery and development of therapies that deepen responses, remissions and hope in driving toward a future where we look to deliver cures. Learn how we’re striving to get in front of cancer this World Cancer Research Day: https://bit.ly/3EML7ep #WorldCancerResearchDay #CancerResearch #Innovation #JNJOncology

Janssen is taking on a range of common diseases of the retina, like geographic atrophy (GA). GA is an advanced form of age-related macular degeneration (AMD), and a leading cause of irreversible vision loss. This disease affects over 8 million people worldwide and is a leading cause of blindness in people over 65 years of age worldwide. GA causes central vision loss, making it difficult for patients to accomplish everyday tasks, such as reading, driving, cooking, or even seeing faces. Learn more about our commitment to reduce the patient burden for those living with GA this World Retina Day: https://bit.ly/3ETD1AF #JanssenRetina #GeographicAtrophy #WorldRetinaDay

We believe a culture of inclusion is rooted in understanding and welcoming to all people with different cultures, abilities, backgrounds, and perspectives. Celebrate Hispanic and Latino cultures by understanding what values they bring. #HispanicHeritageMonth #LatinoHeritageMonth #HHM2023

A force for positive disruption." Innovative individuals, like Luis Roman, are what drive Johnson & Johnson Innovative Medicine —and the industry—toward a healthier future. Congratulations on this PharmaVoice honor!

Alzheimer’s disease is a degenerative, progressive brain disease accounting for 60-80% of demetia cases, and with each diagnosis comes much uncertainty for both the patient and their loved ones. Read the article below to learn from patients and caregivers about common misconceptions associated with this disease, and how we can better understand the experience of those living with it.   #WorldAlzDay #WorldAlzMonth #ENDALZ #AlzheimersDisease

We are looking forward to gathering with a diverse and inspiring group of patient advocates this weekend at HealtheVoices 2023, a conference created by and for advocates. Many of the mainstage sessions will be livestreamed. Register today to tune in to presentations on topics like health literacy, representation in healthcare, and influencer burnout – and catch a keynote talk from filmmaker and patient advocate, Jennifer Brea. To access the conference agenda and instructions for joining virtually, visit https://lnkd.in/eCbktZe3.  #HealtheVoices23 #HealtheVoices #HealtheVoicesLIVE #PatientAdvocacy

At Janssen, we are passionate about transforming care for people living with pulmonary hypertension (PH). Hear our regional leaders discuss our commitment to PH. #PulmonaryHypertension